Literature DB >> 6747819

Hepatic elimination of drugs with concentration-dependent serum protein binding.

J D Huang, S Oie.   

Abstract

For a drug with concentration-dependent serum protein binding, the unbound fraction of drug decreases during the drug elimination process. The clearance of the drug at a given blood flow rate is lower than would be expected from the observed unbound fraction in venous blood from a noneliminating organ. Based on both the "well-stirred" and "parallel tube" models, simulations demonstrated that consideration of concentration-dependent binding during drug elimination is important when the intrinsic clearance is higher than the blood flow and when the unbound drug concentration is much greater than the dissociation equilibrium constant of the binding complex.

Mesh:

Substances:

Year:  1984        PMID: 6747819     DOI: 10.1007/BF01063611

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  7 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.

Authors:  P J McNamara; G Levy; M Gibaldi
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

3.  Theoretic aspects of pharmacokinetic drug interactions.

Authors:  J R Gillette; K S Pang
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

4.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

5.  Effect of saturable binding on the pharmacokinetics of drugs: a simulation.

Authors:  S Oie; T W Guentert; T N Tozer
Journal:  J Pharm Pharmacol       Date:  1980-07       Impact factor: 3.765

6.  Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.

Authors:  J A Jansen
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12
  7 in total
  4 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

2.  Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.

Authors:  M E Morris; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

3.  Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.

Authors:  X Xu; P Selick; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

4.  Saturable elimination and saturable protein binding account for flavone acetic acid pharmacokinetics.

Authors:  M V Relling; R R Evans; S Groom; W R Crom; C B Pratt
Journal:  J Pharmacokinet Biopharm       Date:  1993-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.